The US International Development Finance Corporation (DFC) has approved an investment of USD 25 million (approximately Rs 212 crore) to support affordable healthcare in India. This investment is part of the projects approved by the DFC for the first quarter of the US fiscal year (January to March 2025).
In a statement released on Friday, the DFC highlighted the investment, noting that the $25 million funding will be directed to the Somerset Indus Healthcare India Fund III. This fund aims to support small and medium-sized healthcare companies, enhancing access to and affordability of quality healthcare, particularly in Tier 2 and 3 cities in India.
This funding is part of a broader initiative, with the DFC approving 22 new transactions totalling $3 billion for global initiatives. The DFC has previously made numerous investments in India’s private sector, focusing on initiatives aligned with the priorities of both the US and Indian governments, such as advancing health systems (including vaccines), expanding affordable housing and supporting small businesses.
India remains the largest market for the DFC, with an investment of approximately $3.8 billion, including $820 million in new investments made during 2023. The Tribune